ArticleScientific reports2016

Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice.

Arfaxad Reyes-Alcaraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.